BNP Paribas Financial Markets’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-812,820
Closed -$720K 3379
2022
Q4
$720K Sell
812,820
-109,647
-12% -$97.1K ﹤0.01% 1754
2022
Q3
$1.45M Buy
922,467
+833,596
+938% +$1.31M ﹤0.01% 1633
2022
Q2
$179K Buy
88,871
+63,976
+257% +$129K ﹤0.01% 2514
2022
Q1
$58K Sell
24,895
-39,198
-61% -$91.3K ﹤0.01% 2957
2021
Q4
$298K Buy
64,093
+13,817
+27% +$64.2K ﹤0.01% 2618
2021
Q3
$384K Buy
50,276
+40,171
+398% +$307K ﹤0.01% 2276
2021
Q2
$97.9K Sell
10,105
-22,121
-69% -$214K ﹤0.01% 2460
2021
Q1
$267K Buy
32,226
+3,714
+13% +$30.7K ﹤0.01% 2362
2020
Q4
$195K Sell
28,512
-94,136
-77% -$642K ﹤0.01% 2260
2020
Q3
$1.37M Sell
122,648
-149,210
-55% -$1.66M ﹤0.01% 1182
2020
Q2
$1.71M Buy
271,858
+229,252
+538% +$1.44M ﹤0.01% 1123
2020
Q1
$78.4K Buy
42,606
+24,717
+138% +$45.5K ﹤0.01% 2722
2019
Q4
$60.5K Sell
17,889
-401
-2% -$1.36K ﹤0.01% 2877
2019
Q3
$39.1K Buy
18,290
+3,836
+27% +$8.21K ﹤0.01% 2983
2019
Q2
$38.6K Sell
14,454
-9,964
-41% -$26.6K ﹤0.01% 2971
2019
Q1
$116K Buy
+24,418
New +$116K ﹤0.01% 2460
2018
Q4
Sell
-3,343
Closed -$14.7K 3746
2018
Q3
$14.7K Buy
3,343
+500
+18% +$2.2K ﹤0.01% 2896
2018
Q2
$20.5K Buy
+2,843
New +$20.5K ﹤0.01% 2839
2017
Q2
Sell
-240
Closed -$948 3657
2017
Q1
$948 Sell
240
-1,185
-83% -$4.68K ﹤0.01% 3127
2016
Q4
$6.98K Sell
1,425
-252
-15% -$1.24K ﹤0.01% 3026
2016
Q3
$13K Buy
1,677
+555
+49% +$4.3K ﹤0.01% 3101
2016
Q2
$6.28K Buy
+1,122
New +$6.28K ﹤0.01% 3150
2016
Q1
Sell
-5,504
Closed -$47.9K 3189
2015
Q4
$47.9K Sell
5,504
-360
-6% -$3.14K ﹤0.01% 2836
2015
Q3
$49.2K Buy
5,864
+3,504
+148% +$29.4K ﹤0.01% 2877
2015
Q2
$41.6K Buy
+2,360
New +$41.6K ﹤0.01% 2602